GYNAECOLOGY CANCER RESEARCH FUND
The Eve Appeal's vision is a future where fewer women develop and more women survive the five gynaecological cancers. To achieve this vision we raise money to support and fund world-class research into the five gynaecological cancers alongside raising awareness of them. The five gynaecological cancers are ovarian, cervical, vulval, vaginal and womb (also known as endometrial or uterine).
Objects
TO ADVANCE AND FUND RESEARCH INTO GYNAECOLOGICAL CANCERS AND DISSEMINATE THE RESULTS OF SUCH RESEARCH. TO ADVANCE PUBLIC EDUCATION AND THEREBY TO RAISE AWARENESS OF AND THE PROFILE OF GYNAECOLOGICAL CANCERS, THEIR SIGNS AND SYMPTOMS, RISK FACTORS (INCLUDING BRCA AND INHERITED RISKS). TO RELIEVE THE NEEDS OF WOMEN AFFECTED BY GYNAECOLOGICAL CANCERS, AND INHERITED RISK FACTORS (INCLUDING GENETIC MUTATIONS) BY PROVIDING INFORMATION AND SUPPORT SERVICES FOR SUCH WOMEN, THEIR FAMILIES, FRIENDS AND HEALTH AND SOCIAL CARE PROFESSIONALS.?
Financial health, per its FY2025 accounts
The accounts state that the charity ended the year with £389,168 in unrestricted reserves, which is £189,168 above its agreed operating reserve target of £200,000. The charity reported a net surplus for the year and holds an overall cash balance of £1,081,311. The trustees consider the charity to be well-placed to manage risks and have no material uncertainties regarding its ability to continue as a going concern.
What the accounts disclose
“In real terms, £200,000 represents just under three months’ budgeted expenditure, excluding expenditure on research grants and restricted charitable activities.”
“During the year under review, the charity received income totalling £14,550 in donations from 9 Trustees, both current and resigned in the period, including partners (2024: £18,070 from 9 Trustees including partners).” — page 56
“Reed Smith LLP provided pro bono legal services and other support to the charity totalling £50,113 (2024: 80,116). Tamara Box, a partner at Reed Smith LLP is also chair of board of trustee of the charity.” — page 56
“During the year under review, the charity received income totalling £14,550 in donations from 9 Trustees, both current and resigned in the period, including partners (2024: £18,070 from 9 Trustees including partners).” — page 56
“Reed Smith LLP provided pro bono legal services and other support to the charity totalling £50,113 (2024: 80,116). Tamara Box, a partner at Reed Smith LLP is also chair of board of trustee of the charity.” — page 56
“The Charity had one 100% owned subsidiary company in the year. Eve Appeal Limited is a trading company that distributes its profits under Gift Aid to the Charity.” — page 28
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 66
- Government income: £31,351 — grants £31,351 (1); 2% of the £1,729,124 total gross income on the same return
- Employees paid over £60,000: 2 (£70,001–£80,000: 1; £90,001–£100,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 60
- Government income: £143,121 — grants £143,121 (1); 8% of the £1,782,838 total gross income on the same return
- Employees paid over £60,000: 2 (£70,001–£80,000: 1; £90,001–£100,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2023
- Government income: £182,275 — grants £182,275 (1); 14% of the £1,344,858 total gross income on the same return
- Employees paid over £60,000: 2 (£60,001–£70,000: 1; £90,001–£100,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Corporate structure
- Registered company of the charity Companies House 04370087
- Trading subsidiary: EVE APPEAL LIMITED Companies House 04656355 · Financial health read from its filings
- Turnover: £152k
- Profit before tax: £152k
- Donated/gift-aided to the charity: £104k
- },
“Distributions to parent charity under gift aid”
Company officers (Companies House)
- LEVY, Julia Anna on trustee list
- BYRNE, Katharine Helen on trustee list
- DEAN, Emma on trustee list
- O'HARA, Marion Rachel on trustee list
- ROSENTHAL, Adam, Prof. on trustee list
- EKECHI, Christine, Dr on trustee list
- BOX, Mary Tamara on trustee list
- MORRIS, Sarah Louise on trustee list
- COSEC DIRECT LIMITED
Structured financials (annual return, FY ending 31/12/2025)
Register events
- Received assets from another charity (02/01/2018)
Trustees
- Tamara Boxchair
- Adam Rosenthal Prof.
- Christine Ekechi Dr
- Emma Dean
- Ian Jeffrey Jacobs
- Julia Levy
- Katharine Helen Byrne
- Marion O'Hara
- Sally Bailey
- Sarah Morris
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £1.7m | £1.9m |
| 31/12/2024 | £1.8m | £1.7m |
| 31/12/2023 | £1.3m | £1.6m |
| 31/12/2022 | £1.6m | £1.7m |
| 31/12/2021 | £1.5m | £1.1m |
Common questions
Is GYNAECOLOGY CANCER RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that the charity ended the year with £389,168 in unrestricted reserves, which is £189,168 above its agreed operating reserve target of £200,000. The charity reported a net surplus for the year and holds an overall cash balance of £1,081,311. The trustees consider the charity to be well-placed to manage risks and have no material uncertainties regarding its ability to continue as a going concern. Its FY2025 accounts were audited by Moore Kingston Smith LLP.
Who funds GYNAECOLOGY CANCER RESEARCH FUND?
Funders whose own accounts filings name GYNAECOLOGY CANCER RESEARCH FUND as a grant recipient include THE ORR MACKINTOSH FOUNDATION LIMITED, THE PETER STEBBINGS MEMORIAL CHARITY, THE INMAN CHARITY, SANDRA CHARITABLE TRUST, THE GROCERS' CHARITY.
Known funders
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | 11/09/2020 | £9k | Coronavirus Community Support Fund |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE PENNIES FOUNDATION | 3 | £98k |
| THE WILLIAM ALLEN YOUNG CHARITABLE TRUST | 3 | £31k |
| GOWLING WLG (UK) CHARITABLE TRUST | 3 | £7k |
| The Squire Patton Boggs Charitable Trust | 3 | £2k |
| PILKINGTON CHARITIES FUND | 2 | £31k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £15k |
| DUCHY OF LANCASTER BENEVOLENT FUND | 2 | £9k |
| THE FRANK LITCHFIELD GENERAL CHARITABLE TRUST | 2 | £3k |
Charities like this
- OVARIAN CANCER ACTION
- GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")
- OVACOME
- TARGET OVARIAN CANCER
- THE BRITISH GYNAECOLOGICAL CANCER SOCIETY
- Prevent Breast Cancer
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| GYNAECOLOGY CANCER RESEARCH FUND | £1.7m | — | — | above | — | no doubt |
| OVARIAN CANCER ACTION | £1.6m | £150,001 - £160,000 | 3 | unclear | 50.2% | no doubt |
| GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") | £92k | — | 0 | below | — | no doubt |
| OVACOME | £878k | — | — | unclear | — | no doubt |
| TARGET OVARIAN CANCER | £3.4m | £130,001 - £140,000 | — | above | — | no doubt |
| THE BRITISH GYNAECOLOGICAL CANCER SOCIETY | £554k | — | — | above | — | no doubt |